On the heels of Themis deal, CEPI hands Inovio $56M for Lassa fever and MERS vaccines
admin 11th April 2018 Uncategorised 0A month after doling out its first grant ever—to help Themis develop vaccines against Lassa fever and MERS—the Coalition for Epidemic Preparedness Innovations has promised to fund Inovio’s efforts in the same diseases. More: On the heels of Themis deal,
read more